Verition Fund Management LLC - HAEMONETICS CORP MASS ownership

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 50 filers reported holding HAEMONETICS CORP MASS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of HAEMONETICS CORP MASS
ValueSharesWeighting
Q3 2023$16,396,020
+25.3%
18,792
+22.9%
0.19%
+9.1%
Q2 2023$13,088,384
+35.4%
15,292
+35.0%
0.18%
+30.6%
Q1 2023$9,664,840
+30.1%
11,324
-99.9%
0.13%
+15.5%
Q4 2022$7,427,666
+8.2%
8,935,000
-47.9%
0.12%
+48.7%
Q3 2022$6,863,857
+93.7%
17,142,000
+380833.3%
0.08%
+11.4%
Q2 2022$3,544,000
-53.3%
4,500
-100.0%
0.07%
-23.1%
Q1 2022$7,585,0009,000,0000.09%
Other shareholders
HAEMONETICS CORP MASS shareholders Q4 2022
NameSharesValueWeighting ↓
Wellesley Asset Management 48,416$41,563,0002.83%
HPS Investment Partners, LLC 5,419$4,567,0001.76%
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,169,0000.83%
ADVENT CAPITAL MANAGEMENT /DE/ 48,979,000$41,243,0000.66%
Aequim Alternative Investments LP 20,500,000$17,276,0000.46%
Kohlberg Kravis Roberts & Co. L.P. 45,394,000$38,255,0000.35%
Quaero Capital S.A. 900,000$757,0000.26%
OAKTREE CAPITAL MANAGEMENT LP 21,614,000$18,214,0000.19%
Brandywine Global Investment Management, LLC 29,515,000$24,873,0000.18%
AVIVA PLC 38,300,000$32,126,0000.16%
View complete list of HAEMONETICS CORP MASS shareholders